Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Institut du Cancer de Montpellier - Val d'Aurelle
Jonsson Comprehensive Cancer Center
University of Nebraska
Merck Sharp & Dohme LLC
Jonsson Comprehensive Cancer Center
Turning Point Therapeutics, Inc.
Hoffmann-La Roche
Instituto do Cancer do Estado de São Paulo
Nanjing First Hospital, Nanjing Medical University